Generation of recombinant and chickenized scFv versions of an anti‐kinesin monoclonal antibody H2
Cytoskeleton · 2023
DOI: 10.1002/cm.21756 ↗At a glance
Journal article in Cytoskeleton, 2023. Written by Shinsuke Niwa and 1 co-authors. Institution: Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University, Aramaki-Aoba 6-3, Aoba-Ku, Sendai, Miyagi, 980-0845, Japan. Major MEDLINE topics: Antibodies, Monoclonal, Single-Chain Antibodies, Kinesins. Cited 2 times so far (Crossref); 57 references. Funded by: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Uehara Memorial Foundation.
Abstract (original language)
Kinesin‐1, a motor protein composed of the kinesin heavy chain (KHC) and the kinesin light chain (KLC), is essential for proper cellular morphogenesis and function. A monoclonal antibody (mAb) called H2 recognizes the KHC in a broad range of species and is one of the most widely used mAbs in cytoskeletal motor research. Here, we present vectors that express recombinant H2 in mammalian cells. We show the recombinant H2 performs as well as the hybridoma‐derived H2 in both western blotting and immunofluorescence assays. Additionally, the recombinant H2 can detect all three human KHC isotypes (KIF5A, KIF5B, and KIF5C) and amyotrophic lateral sclerosis‐associated KIF5A aggregates in cells. In addition, we developed a chickenized version of the H2 mAb's single chain variable fragment, which can be used in immunofluorescence microscopy and expands the potential applications of H2. Overall, our results demonstrate that recombinant H2 is a useful tool for studying the functions of KHCs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Frontier Research Institute for Interdisciplinary Sciences (FRIS), Tohoku University, Aramaki-Aoba 6-3, Aoba-Ku, Sendai, Miyagi, 980-0845, Japan.
ORCID profiles: Shinsuke Niwa
Funding
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Uehara Memorial Foundation
Cite
APA
Niwa, S., & Chiba, K. (2023). Generation of recombinant and chickenized scFv versions of an anti‐kinesin monoclonal antibody H2. Cytoskeleton. https://doi.org/10.1002/cm.21756
Vancouver
Niwa S, Chiba K. Generation of recombinant and chickenized scFv versions of an anti‐kinesin monoclonal antibody H2. Cytoskeleton. 2023. doi:10.1002/cm.21756
BibTeX
@article{Niwa2023,
author = {Niwa, Shinsuke and Chiba, Kyoko},
title = {Generation of recombinant and chickenized scFv versions of an anti‐kinesin monoclonal antibody H2},
journal = {Cytoskeleton},
year = {2023},
doi = {10.1002/cm.21756}
}
EUVIMED